Tremfya 100 MG/ML one-pressml
Ended Awarded Last action
- Contract number
- SPE2DR26FFL4Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,723
Award facts
- Contract value 100% obligated
- $31,722.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 27, 2026, represents a $31,722.78 firm fixed-price purchase of TREMFYA 100 MG/ML (guselkumab injection), a biologic immunosuppressant medication used to treat plaque psoriasis and other inflammatory conditions. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with performance at the same location. The Defense Logistics Agency, which funds the award, utilized no set-aside designation, indicating the contract was competitively awarded. This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s substantially larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to military healthcare programs globally.
The contract reflects the Defense Logistics Agency's critical role in ensuring military treatment facilities and veterans' healthcare programs have access to specialty pharmaceutical products necessary for service member and veteran care. AmerisourceBergen's extensive federal contract portfolio and existing large-value IDC with DLA demonstrate the company's established capability to meet rigorous government procurement standards for pharmaceutical distribution. The January 28, 2026 completion date indicates rapid fulfillment typical of standard pharmaceutical delivery orders supporting ongoing military medical operations.
Quick answers
Who was awarded contract SPE2DR26FFL4Z?
SPE2DR26FFL4Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FFL4Z worth?
The government has obligated $31,723 on SPE2DR26FFL4Z.
Is contract SPE2DR26FFL4Z an order under another contract?
Yes. SPE2DR26FFL4Z is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL4Z competed?
The extent of competition for SPE2DR26FFL4Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award